Health Information Portal (HIP)

The Philadelphia Department of Public Health (PDPH) HAI/AR Program conducts year-round surveillance for multiple drug-resistant organisms of public health concern by collecting clinical and laboratory information from healthcare facilities. The HAI/AR Program also monitors and tracks numerous healthcare-associated infections and metrics that are reported into the Centers for Disease Control and Prevention’s (CDC) National Healthcare Safety Network (NHSN), the nation’s most widely used healthcare-associated infections tracking system.

Posting of this data is intended for the purpose of promoting the health of Philadelphia residents and for providing a reference to healthcare providers citywide to inform practice in their own institutions. PDPH attempts to post timely and reliable information, but due to the limitations of the surveillance systems used to generate these data, we cannot guarantee that all data is complete or up-to-date.

Click here to view the latest report of healthcare-associated infections in a printable form.

Carbapenem-resistant Enterobacteriaceae (CRE): July - September 2024

CRE Cases, by Carbapenemase-Producing (CP) Status: October 2023 - September 2024

Candida Auris

Candida auris is an emerging threat in the Philadelphia region, The first C. auris case was reported in March 2020 in an individual who likely acquired the organism out of state; however, the cases in August and September are part of a local healthcare facility cluster. For more information, see the joint Health Alert by PDPH and PADOH or the C. auris webpage.

Suspected or confirmed cases of C. auris should be reported to PDPH by calling 215-685-6748 within 24 hours. Complete the Candida auris Report Form and fax to 215-238-6947 after reporting the case by phone.